|
1
|
NCD Risk Factor Collaboration (NCD-RisC),
. Worldwide trends in body-mass index, underweight, overweight, and
obesity from 1975 to 2016: A pooled analysis of 2416
population-based measurement studies in 128·9 million children,
adolescents, and adults. Lancet. 390:2627–2642. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iyengar NM, Morris PG, Hudis CA and
Dannenberg AJ: Obesity, inflammation, and breast cancer. Obesity,
Inflammation and Cancer. Dannenberg A and Berger N: Springer; New
York, NY: pp. 181–217. 2013, View Article : Google Scholar
|
|
3
|
Yoon HH, Lewis MA, Shi Q, Khan M, Cassivi
SD, Diasio RB and Sinicrope FA: Prognostic impact of body mass
index stratified by smoking status in patients with esophageal
adenocarcinoma. J Clin Oncol. 29:4561–4567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iyengar NM, Hudis CA and Dannenberg AJ:
Obesity and inflammation: New insights into breast cancer
development and progression. Am Soc Clin Oncol Educ Book. 33:46–51.
2013. View Article : Google Scholar
|
|
5
|
van Kruijsdijk RC, van der Wall E and
Visseren FL: Obesity and cancer: The role of dysfunctional adipose
tissue. Cancer Epidemiol Biomarkers Prev. 18:2569–2578. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Durko L and Malecka-Panas E: Lifestyle
modifications and colorectal cancer. Curr Colorectal Cancer Rep.
10:45–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamaji T, Iwasaki M, Sasazuki S and
Tsugane S: Interaction between adiponectin and leptin Influences
the risk of colorectal adenoma. Cancer Res. 70:5430–5437. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Otake S, Takeda H, Fujishima S, Fukui T,
Orii T, Sato T, Sasaki Y, Nishise S and Kawata S: Decreased levels
of plasma adiponectin associated with increased risk of colorectal
cancer. World J Gastroenterol. 16:1252–1257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kumor A, Daniel P, Pietruczuk M and
Malecka-Panas E: Serum leptin, adiponectin, and resistin
concentration in colorectal adenoma and carcinoma (CC) patients.
Int J Colorectal Dis. 24:275–281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nowakowska-Zajdel E, Wierzchowiec O, Kokot
T, Fatygaa E and Muc-Wierzgon M: Metabolic abnormalities in
colorectal cancer patients. J Endocrinol Metab. 2:135–138.
2012.
|
|
12
|
Halberg N, Wernstedt-Asterholm I and
Scherer PE: The adipocyte as an endocrine cell. Endocrinol Metab
Clin North Am. 37:753–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trujillo ME and Scherer PE: Adipose
tissue-derived factors: Impact on health and disease. Endocr Rev.
27:762–789. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paz-Filho G, Lim EL, Wong ML and Licinio
J: Associations between adipokines and obesity-related cancer.
Front Biosci (Landmark Ed). 16:1634–1650. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Balistreri CR, Caruso C and Candore G: The
role of adipose tissue and adipokines in obesity-related
inflammatory diseases. Mediators Inflamm. 2010:8020782010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wrackmeyer U, Hansen GH, Seya T and
Danielsen EM: Intelectin: A novel lipid raft-associated protein in
the enterocyte brush border. Biochemistry. 45:9188–9197. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang RZ, Lee MJ, Hu H, Pray J, Wu HB,
Hansen BC, Shuldiner AR, Fried SK, McLenithan JC and Gong DW:
Identification of omentin as a novel depot-specific adipokine in
human adipose tissue: Possible role in modulating insulin action.
Am J Physiol Endocrinol Metab. 290:E1253–E1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sepandar F, Rashidbeygi E, Maghbooli Z,
Khorrami-Nezhad L, Hajizadehoghaz M and Mirzaei K: The association
between resting metabolic rate and metabolic syndrome May Be
mediated by adipokines in overweight and obese women. Diabetes
Metab Syndr. 13:530–534. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li F, Pang LZ, Zhang L, Zhang Y, Zhang YY,
Yu BY and Kou JP: YiQiFuMai powder injection ameliorates chronic
heart failure through cross-talk between adipose tissue and
cardiomyocytes via up-regulation of circulating adipokine omentin.
Biomed Pharmacother. 119:1094182019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zabetian-Targhi F, Mirzaei K, Keshavarz SA
and Hossein-Nezhad A: Modulatory Role of omentin-1 in inflammation:
Cytokines and dietary intake. J Am Coll Nutr. 35:670–678. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Briana DD and Malamitsi-Puchner A:
Intrauterine growth restriction: The controversial role of
perinatal adipocytokines in the prediction of metabolic adult
disease. J Matern Fetal Neonatal Med. 1–6. 2019:Sept 25–2019.(Epub
ahead of print). doi: 10.1080/14767058.2019.1669556.). View Article : Google Scholar
|
|
22
|
Fazeli MS, Dashti H, Akbarzadeh S, Assadi
M, Aminian A, Keramati MR and Nabipour I: Circulating levels of
novel adipocytokines in patients with colorectal cancer. Cytokine.
62:81–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aleksandrova K, di Giuseppe R, Isermann B,
Biemann R, Schulze M, Wittenbecher C, Fritsche A, Lehmann R, Menzel
J, Weikert C, et al: Circulating omentin as a novel biomarker for
colorectal cancer risk: Data from the EPIC-Potsdam cohort study.
Cancer Res. 76:3862–3871. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan C, Xiaotong Zhao and Mingwei C: A
study on relationship of adipokine omentin-1 involved in colorectal
cancer. Acta Univ Med Anhui. 1:75–78. 2015.
|
|
25
|
Qin Y, Huo ZB, Song X, Chen X, Tian X and
Wang X: mir-106a regulates cell proliferation and apoptosis of
colon cancer cells through targeting the PTEN/PI3K/AKT signaling
pathway. Oncol Lett. 15:3197–3201. 2018.PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Booth A, Magnuson A, Fouts J and Foster M:
Adipose tissue, obesity and adipokines: Role in cancer promotion.
Horm Mol Biol Clin Investig. 21:57–74. 2015.PubMed/NCBI
|
|
28
|
Yang G, Fan W, Luo B, Xu Z, Wang P, Tang
S, Xu P and Yu M: Circulating resistin levels and risk of
colorectal cancer: A Meta-analysis. Biomed Res Int.
2016:73674852016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang YY and Zhou LM: Omentin-1, a new
adipokine, promotes apoptosis through regulating Sirt1-dependent
p53 deacetylation in hepatocellular carcinoma cells. Eur J
Pharmacol. 698:137–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Washimi K, Yokose T, Yamashita M, Kageyama
T, Suzuki K, Yoshihara M, Miyagi Y, Hayashi H and Tsuji S: Specific
expression of human intelectin-1 in malignant pleural mesothelioma
and gastrointestinal goblet cells. PLoS One. 7:398892012.
View Article : Google Scholar
|
|
31
|
Uyeturk U, Sarıci H, Kın Tekce B, Eroglu
M, Kemahl E, Uyeturk U and Gucuk A: Serum omentin level in patients
with prostate cancer. Med Oncol. 31:9232014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kawashima K, Maeda K, Saigo C, Kito Y,
Yoshida K and Takeuchi T: Adiponectin and intelectin-1: Important
adipokine players in obesity-related colorectal Carcinogenesis. Int
J Mol Sci. 18(pii): E8662017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jaikanth C, Gurumurthy P, Cherian KM and
Indhumathi T: Emergence of omentin as a pleiotropic adipocytokine.
Exp Clin Endocrinol Diabetes. 121:377–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ghaemmaghami S, Mohaddes SM, Hedayati M,
Gorgian Mohammadi M and Dehbashi G: Resistin and visfatin
expression in HCT-116 colorectal cancer cell line. Int J Mol Cell
Med. 2:143–150. 2012.
|
|
35
|
Li XT, Wan LJ, Zhang QH, Chen MW, Xia TJ,
Xu M and Tang SG: Effects of omentin-1 gene silence on
proliferation and apoptosis of colon cancer cells. Acta Univ Med
Anhui. 54:60–63. 2019.
|
|
36
|
Tan BK, Adya R, Farhatullah S, Lewandowski
KC, O'Hare P, Lehnert H and Randeva HS: Omentin-1, a novel
adipokine, is decreased in overweight insulin-resistant women with
polycystic ovary syndrome: Ex vivo and in vivo regulation of
omentin-1 by insulin and glucose. Diabetes. 57:801–808. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan HY, Guo L and Li Q: Changes of serum
omentin-1levels in normal subjects and in patients with impaired
glucose regulation and with newly diagnosed and untreated type 2
diabetes. Diabetes Res Clin Pract. 88:29–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
de Souza Batista CM, Yang RZ, Lee MJ,
Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman
M, et al: Omentin plasma levels and gene expression are decreased
in obesity. Diabetes. 56:1655–1661. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tan BK, Adya R and Randeva HS: Omentin: A
novel link between inflammation, diabesity, and cardiovascular
disease. Trends Cardiovasc Med. 20:143–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shibata R, Takahashi R, Kataoka Y, Ohashi
K, Ikeda N, Kihara S, Murohara T and Ouchi N: Association of
fat-derived plasma protein omentin with carotid artery intima-media
thickness in apparently healthy men. Hypertens Res. 34:1309–1312.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Greulich S, Chen WJ, Maxhera B, Rijzewijk
LJ, van der Meer RW, Jonker JT, Mueller H, de Wiza DH, Floerke RR,
Smiris K, et al: Cardioprotective properties of omentin-1 in type 2
diabetes: Evidence from clinical and in vitro studies. PLoS One.
8:e596792013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yamawaki H, Kuramoto J, Kameshima S, Usui
T, Okada M and Hara Y: Omentin, a novel adipocytokine inhibits
TNF-induced vascular inflammation in human endothelial cells.
Biochem Biophys Res Commun. 408:339–343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kazama K, Usui T, Okada M, Hara Y and
Yamawaki H: Omentin plays an anti-inflammatory role through
inhibition of TNF-α-induced superoxide production in vascular
smooth muscle cells. Eur J Pharmacol. 686:116–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Moreno-Navarrete JM, Ortega F, Castro A,
Sabater M, Ricart W and Fernández-Real JM: Circulating omentin as a
novel biomarker of endothelial dysfunction. Obesity (Silver
Spring). 19:1552–1559. 2011. View Article : Google Scholar : PubMed/NCBI
|
